“We are aware that the majority of malignancies are truly undetectable at this phase, which is now known as the pre-cancer stage.
Thus, the vaccine’s goal is to really protect against that pre-cancer stage rather than to vaccinate against cancer that has already spread.”
In addition to discovering additional malignancies, the university has previously established itself as a leader in vaccine development, most notably.
The first Covid-19 vaccinations. The initiative is part of the GSK-Oxford Cancer Immuno-Prevention Program.
The new study aims to potentially vaccinate cancer patients before the disease even begins to spread. Researchers have previously discovered tumor-specific proteins.
That vaccinations might block to prevent cancer from returning. Vice-Chancellor of Oxford University Professor Irene Tracey hailed.
